Board on Life Sciences; National Research Council; National Academy of Sciences; Leslie Z. Benet; Jane S. Durch; Joellenbeck National Academies Press (2004) Pehmeäkantinen kirja
Board on Children, Youth, and Families; Leslie J. Sim; Jennifer Appleton Gootman; Robert S. Lawrence National Academies Press (2009) Kovakantinen kirja
National Research Council; Division of Behavioral and Social Sciences and Education; Board on Testing and Assessment; Board on S National Academies Press (2011) Pehmeäkantinen kirja
National Research Council; Division of Behavioral and Social Sciences and Education; Board on Testing and Assessment; Board on S National Academies Press (2013) Pehmeäkantinen kirja
Board on Children, Youth, and Families; Commission on Behavioral and Social Sciences and Education; Division of Behavioral and S National Academies Press (1996) Pehmeäkantinen kirja
Board on Agriculture and Natural Resources; Division on Earth and Life Studies; National Research Council; National Academy of S National Academies Press (2000) Pehmeäkantinen kirja
National Research Council; Division on Earth and Life Studies; Board on Environmental Studies and Toxicology; Committee on EPA's National Academies Press (2006) Pehmeäkantinen kirja
Institute of Medicine; Board on Health Sciences Policy; Committee on Review of NASA's Bioastronautics Critical Path Roadmap National Academies Press (2005) Pehmeäkantinen kirja
National Research Council; Division on Earth and Life Studies; Board on Atmospheric Sciences and Climate; America's Climate Choi National Academies Press (2011) Pehmeäkantinen kirja
National Research Council; Division on Earth and Life Studies; Board on Atmospheric Sciences and Climate; America's Climate Choi National Academies Press (2011) Pehmeäkantinen kirja
National Research Council; Division on Earth and Life Studies; Board on Atmospheric Sciences and Climate; America's Climate Choi National Academies Press (2011) Pehmeäkantinen kirja
National Research Council; Division on Earth and Life Studies; Board on Atmospheric Sciences and Climate; America's Climate Choi National Academies Press (2011) Pehmeäkantinen kirja
Committee on Women's Health Research; Board on Population Health and Public Health Practice; Institute of Medicine National Academies Press (2010) Pehmeäkantinen kirja
Institute of Medicine; Board on the Health of Select Populations; Committee on the Review of the Appropriate Use of AFIP's Tissu National Academies Press (2013) Pehmeäkantinen kirja
Institute of Medicine; Board on the Health of Select Populations; Committee on the Review of the Department of Labor's Site Expo National Academies Press (2013) Pehmeäkantinen kirja
National Research Council; Division on Earth and Life Studies; Board on Atmospheric Sciences and Climate; Committee on America's National Academies Press (2011) Pehmeäkantinen kirja
Panel for Collaborative Research Support for AID's Sustainable Agriculture and Natural Resource Management Program; Board on Agr National Academies Press (1991) Pehmeäkantinen kirja
Committee on the Department of Energy-Office of Science and Technology's Peer Review Program; Board on Radioactive Waste Managem National Academies Press (1999) Pehmeäkantinen kirja
In recent years, substantial efforts have been initiated to develop new drugs, vaccines, and other medical interventions against biological agents that could be used in bioterrorist attacks against civilian populations. According to a new congressionally mandated report from the Institute of Medicine and National Research Council of the National Academies, to successfully develop these drugs, vaccines, and other medical interventions against biowarfare agents, Congress should authorize the creation of a new agency within the Office of the Secretary of the U.S. Department of Defense. The committee recommended that Congress should improve liability protections for those who develop and manufacture these products, to stimulate willingness to invest in new research and development for biowarfare protection. Giving Full Measure to Countermeasures also identifies other challengesa "such as the need for appropriate animal models and laboratories equipped with high-level biosafety protectionsa "that will require attention if DoD efforts to develop new medical countermeasures are to be successful.
